Sondra Berger

Title
InstitutionMedical University of South Carolina
DepartmentSCCP Pharmaceutical and Biomedical Sciences - USC Campus
Address
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. El-Mesallamy HO, El Magdoub HM, Chapman JM, Hamdy NM, Schaalan MF, Hammad LN, Berger SH, El-Mesallamy HO, El Magdoub HM, Chapman JM, Hamdy NM, Schaalan MF, Hammad LN, Berger SH. Biomolecular study of human thymidylate synthase conformer-selective inhibitors: New chemotherapeutic approach. PLoS One. 2018; 13(3):e0193810. PMID: 29538414; PMCID: PMC5851609.
      Citations:    
    2. Luo B, Johnson SR, Lebioda L, Berger SH, Luo B, Johnson SR, Lebioda L, Berger SH. Evolution of metamorphism in thymidylate synthases within the primate lineages. J Mol Evol. 2011 Mar; 72(3):306-14. PMID: 21318388.
      Citations:    
    3. Luo B, Repalli J, Yousef AM, Johnson SR, Lebioda L, Berger SH, Luo B, Repalli J, Yousef AM, Johnson SR, Lebioda L, Berger SH. Human thymidylate synthase with loop 181-197 stabilized in an inactive conformation: ligand interactions, phosphorylation, and inhibition profiles. Protein Sci. 2011 Jan; 20(1):87-94. PMID: 21064161; PMCID: PMC3047064.
      Citations:    
    4. Huang X, Gibson LM, Bell BJ, Lovelace LL, Peña MM, Berger FG, Berger SH, Lebioda L, Huang X, Gibson LM, Bell BJ, Lovelace LL, Pe?a MM, Berger FG, Berger SH, Lebioda L. Replacement of Val3 in human thymidylate synthase affects its kinetic properties and intracellular stability . Biochemistry. 2010 Mar 23; 49(11):2475-82. PMID: 20151707; PMCID: PMC2856444.
      Citations:    
    5. Lovelace LL, Johnson SR, Gibson LM, Bell BJ, Berger SH, Lebioda L, Lovelace LL, Johnson SR, Gibson LM, Bell BJ, Berger SH, Lebioda L. Variants of human thymidylate synthase with loop 181-197 stabilized in the inactive conformation. Protein Sci. 2009 Aug; 18(8):1628-36. PMID: 19569192; PMCID: PMC2776951.
      Citations:    
    6. Berger SH, Pittman DL, Wyatt MD, Berger SH, Pittman DL, Wyatt MD. Uracil in DNA: consequences for carcinogenesis and chemotherapy. Biochem Pharmacol. 2008 Sep 15; 76(6):697-706. PMID: 18599024; PMCID: PMC2562027.
      Citations:    
    7. Berger FG, Berger SH, Berger FG, Berger SH. Thymidylate synthase as a chemotherapeutic drug target: where are we after fifty years? Cancer Biol Ther. 2006 Sep; 5(9):1238-41. PMID: 17035726.
      Citations:    
    8. Adams SA, Hebert JR, Bolick-Aldrich S, Daguise VG, Mosley CM, Modayil MV, Berger SH, Teas J, Mitas M, Cunningham JE, Steck SE, Burch J, Butler WM, Horner MJ, Brandt HM, Adams SA, Hebert JR, Bolick-Aldrich S, Daguise VG, Mosley CM, Modayil MV, Berger SH, Teas J, Mitas M, Cunningham JE, Steck SE, Burch J, Butler WM, Horner MJ, Brandt HM. Breast cancer disparities in South Carolina: early detection, special programs, and descriptive epidemiology. J S C Med Assoc. 2006 Aug; 102(7):231-9. PMID: 17319236; PMCID: PMC2965587.
      Citations:    
    9. You S, Ohmori M, Peña MM, Nassri B, Quiton J, Al-Assad ZA, Liu L, Wood PA, Berger SH, Liu Z, Wyatt MD, Price RL, Berger FG, Hrushesky WJ, You S, Ohmori M, Pe?a MM, Nassri B, Quiton J, Al-Assad ZA, Liu L, Wood PA, Berger SH, Liu Z, Wyatt MD, Price RL, Berger FG, Hrushesky WJ. Developmental abnormalities in multiple proliferative tissues of Apc(Min/+) mice. Int J Exp Pathol. 2006 Jun; 87(3):227-36. PMID: 16709231; PMCID: PMC2517368.
      Citations:    
    10. Li L, Connor EE, Berger SH, Wyatt MD, Li L, Connor EE, Berger SH, Wyatt MD. Determination of apoptosis, uracil incorporation, DNA strand breaks, and sister chromatid exchanges under conditions of thymidylate deprivation in a model of BER deficiency. Biochem Pharmacol. 2005 Nov 15; 70(10):1458-68. PMID: 16191427.
      Citations:    
    11. Li L, Berger SH, Wyatt MD, Li L, Berger SH, Wyatt MD. Involvement of base excision repair in response to therapy targeted at thymidylate synthase. Mol Cancer Ther. 2004 Jun; 3(6):747-53. PMID: 15210861.
      Citations:    
    12. Berger SH, Berger FG, Lebioda L, Berger SH, Berger FG, Lebioda L. Effects of ligand binding and conformational switching on intracellular stability of human thymidylate synthase. Biochim Biophys Acta. 2004 Jan 14; 1696(1):15-22. PMID: 14726200.
      Citations: 27     Fields:    Translation:HumansCells
    Berger's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (97)
    Explore
    _
    Co-Authors (7)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _